Epigenetic carcinogens: Evaluation and risk assessment

Experimental and Toxicologic Pathology

Volumn 48, Issue 2-3, 1996, Pages 189-195

  Williams, Gary M ^a   Whysner, John ^a  

^a AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

Carcinogens, epigenetic; Epigenetic carcinogens; Risk assessment, epigenetic carcinogens

Indexed keywords

BUTYLATED HYDROXYANISOLE; CARCINOGEN; LIMONENE; PHENOBARBITAL; SACCHARIN;

ANIMAL MODEL; CANCER; CANCER RISK; CONFERENCE PAPER; CONTROLLED STUDY; NONHUMAN; RODENT;

ANIMALIA; RODENTIA; UNIDENTIFIED AGENTS;

EID: 0029873622     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0940-2993(96)80041-8     Document Type: Conference Paper

References (55)

1. ALBERTINI S, GOCKE E: Phenobarbital: Does the positive result in TA1535 indicate genotoxic properties'? Environ Mol Mutagen 1992; 19: 161-166.
2. APPEL KE, MENDEN M, BUCHMANN A, et al.: Effect of varying the concentration of phenobarbital and its duration of treatment on the evolution of carcinogen induced enzyme-altered foci in rat liver. Cancer Lett 1991; 57: 75-82.
3. ARMITAGE P, DOLL R: The age distribution of cancer and multistage theory of carcinogenesis. Br J Cancer 1954; 8: 1-12.
4. ARNOLD DL, MOODIE CA, GRICE HC, et al.: Long-term toxicity of ortho-toluenesulfonamide and sodium saccharin in the rat. Tolxicol Appl Pharmacol 1980; 54: 113-152.
5. 2u-globulin association with chemically induced renal toxicity and neoplasia in the male rat. Prepared for the Risk Assessment Forum. United States Environmental Protection Agency, Washington D.C. 1991.
6. BERENBLUM I, NEUBERGER A, TATUM EL (eds.): Carcinogenesis as a Biological problem. North-Holland Amsterdam; 1974.
7. CLAYSON DB, IVERSON F, NERA E, et al.: Histopathological and radioautographical studies on the forestomach of F344 rats treated with butylated hydroxyanisole and related chemicals. Food Chem Toxicol 1986; 24: 1171-1182.
8. COHEN SM, ARAI M, JACOBS JB, et al.: Promoting effect of saccharin and dl-tryptophan in urinary bladder carcinogenesis. Cancer Res 1979, 39: 1207-1217.
9. COHEN SM, ELLWEIN LB, OKAMURA T, et al.: Comparative bladder tumor promoting activity of sodium saccharin, sodium ascorbate, related acids and calcium salts in rats. Cancer Res 1991; 51: 1766-1777.
10. Commission of the European Communities (CEC): Commission Directive 93/67/EEC of July 1993. Official Journal of the European Communities 1993; L (227): 9-18.
11. 2u) nephropathy. Fundam Appl Toxicol 1991a; 16: 749:762.
12. 2u-Globulin is necessary for d-limonene promotion of male rat kidney tumors. Cancer Res 1991b; 51: 3512-3521.
13. ELLWEIN LB, COHEN SM: The health risks of saccharin rivisited. Crit Rev Toxicol 1990; 20: 311-326.
14. GOLDSWORTHY T, CAMPBELL HA, PITOT HC: The natural history and dose response characteristics of enzyme-altered foci in rat liver following phenobarbital and diethylnitrosamine administration. Carcinogenesis 1984; 5: 67-71.
15. HARD GC, WHYSNER J: Risk Assessment of d-Limonene: An Example of Male Rat-Specific Renal Tumorigens. Crit Rev Toxicol 1994; 24: 231-254.
16. HASEGAWA R, COHEN SM: The effect of different salts of saccharin on the rat urinary bladder. Cancer Lett 1986; 30: 261-268.
17. Health Council of the Netherlands: Risk assessment of carcinogenic chemicals in The Netherlands. Regul Toxicol Pharmacol 1994; 19: 14-30.
18. HIROSE M, HAGIWARA A, INOUE K, et al.: Metabolism of 2-and 3-tert-butyl-4-hydroxyanisole (2- and 3-BHA) in the rat (I): Excretion of BHA in urine, feces and expired air and distribution of BHA in the main organs. Toxicology 1987; 43: 139-147.
19. IARC (eds.): IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans: Some naturally occurring and synthetic food components, furocoumarins and ultraviolet radiation. IARC Lyon 1986 pp. 126.
20. IARC (eds.): IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. The Overall Evaluation of Carcinogenicity: An Updating of IARC Monographs. Volumes 1 to 42, Supplement 7 IARC Lyon 1987 pp. 40-42.
21. IARC (eds.): IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Occupational Exposures in Insecticide Application and Some Pesticides, Volume 53 IARC Lyon 1991.
22. ISHIDATE M, SOFUNI T, YOSHIKAWA K, et al.: Primary mutagenicity screening of food additives currently used in Japan. Food Chem Toxicol 1984; 22: 623-636.
23. ITO N, FUKUSHIMA S, TAMANO S, et al.: Dose response in butylated hydroxyanisole induction of forestomach carcinosenesis in F344 rats. J Natl Cancer Inst 1986; 77: 1261-1265.
24. Joint FAOAVHO Expert Consultation: Application of risk analysis to food standards issues. World Health Organization Geneva 1995.
25. KANERVA RL, RIDDER GM, LEFEVER FR, et al.: Comparison of short-term renal effects due to oral administration of decalin or d-limonene in young adult male Fischer-344 rats. Food Chem Toxicol 1987; 25: 345-353.
26. 2u-globulin. Toxicol Appl Pharmacol 1989; 99: 250-259.
27. MAEKAWA A, ONODERA H, OGASAWARA H, et al.: Threshold dose dependence in phenobarbital promotion of rat hepatocarcinogenesis initiated by diethylnitrosamine. Carcinogenesis 1992; 13: 501-503.
28. MCCLAIN RM: Mouse liver tumors and microsomal enzyme-inducing drugs: Experimental and clinical perspectives with phenobarbital. Clin Biol Res 1990; 331: 345-365.
29. OLSON MJ, JOHNSON JT, REIDY CA: A comparison of male rat and human urinary proteins: implications for human resistance to hyaline droplet nephropathy. Toxicol Appl Pharmacol 1990; 102: 524-536.
30. OLSEN JH, SCHULGEN G, BOICE JD, et al.: Antiepileptic treatment and risk for hepatobiliary cancer and malignant lymphoma. Cancer Res 1995; 55: 294-297.
31. OSTP (Office of Science and Technology Policy): Chemical Carcinogens: a review of the science and its associated principles. Fed Reg 1985 pp. 10372-10442.
32. PEREIRA MA, HERREN-FREUND SL, LONG RE: Dose-response relationship of phenobarbital promotion of diethvlnitrosamine initiated tumors in rat liver. Cancer Lett 1986; 32: 305-311.
33. PERAINO C, STAFFELDT EF, HAUGEN DA, et al.: Effects of varying the dietary concentration of phenobarbital on its enhancement of 2-acetylaminofluorene-induced hepatic tumorigenesis. Cancer Res 1980; 40: 3268-3273.
34. PITOT HC, GOLDWORTHY TL, MORAN S, et al.: A method to quantitative the relative initiating and promoting potencies of hepatocarcinogenic agents in their dose-response relationships to altered hepatic foci. Carcinogenesis 1987; 8: 1491-1499.
35. RUCH RJ, KLAUNIG JE: Effects of tumor promoters, genotoxic carcinogens and hepatocytotoxins on mouse hepatocyte intercellular communication. Cell Biol Toxicol 1986; 2: 469-483.
36. 32P-postlabeling method. Cancer Lett 1989; 48: 189-195.
37. SCHOENIG GP, GOLDENTHAL EI, GEIL RG, et al.: Evaluation of the dose response and in utero exposure to saccharin in the rat. Food Chem Toxicol 1985; 23: 475-490.
38. SHIRAI T, FUKUSHIMA S, OHSHIMA M, et al.: Effects of butylated hydroxyanisole, butylated hydroxytoluene and NaCl on gastric carcinogenesis initiated with N-Methyl-N'-nitro-N-nitrosoguanidine in F344 rats. JNCI 1984; 72: 1189-1198.
39. TAKAHASHI M, FURUKAWA F, TOYODA K, et al.: Effects of four antioxidants on N-methyl-N'-nitro-N-nitrosoguamdine initiated gastric tumor development in rats. Cancer Lett 1986; 30: 161-168.
40. TAYLOR JM, WEINBERGER MA, FRIEDMAN L: Chronic toxicity and carcinogenicity to the urinary bladder of sodium saccharin in the in utero-exposed rat. Toxicol Appl Pharmacol 1980, 54: 57-75.
41. TAVOLONI N, JONES MJT, BERK PD: Dose-related effects of phenobarbital on hepatic microsomal enzymes. Proc Soc Exp Biol Med 1983; 174: 20-27.
42. TISDEL MO, NEES PO, HARRIS DL, et al.: Long-term feeding of saccharin in rats. In: AVI (ed.): Symposium: Sweeteners: Proceedings. Westport 1974 pp. 145-158.
43. TROSKO JE, DAWSON B, YOTTI LP, et al.: Saccharin may act as a tumor promoter by inhibiting metabolic cooperation between cells. Nature 1980; 285: 109-110.
44. U.S. Environmental Protection Agency: The risk assessment guidelines of 1986. EPA/600/8-87/045. August 1987; U.S. Environmental Protection Agency Washington DC.
45. WEBB DR, RIDDER GM, ALDEN CL: Acute and subchronic nephrotoxicity of d-limonene in Fischer 344 rats. Fd Chem Toxicol 1989; 27: 639-649.
46. WHYSNER J, WILLIAMS GM: International cancer risk assessment: The impact of biologic mechanisms. Reg Toxicol Pharm 1992; 15: 41-50.
47. WHYSNER J, WANG C, ZANG E, et al.: Dose-response promotion by butylated hydroxyanisole in chemically initiated tumors of the rodent forestomach. Food Chem Toxicol 1994; 32: 215-222.
48. 32P-postlabeling assay for detection of adduct formation by phenobarbital, chlordane and polychlorinated biphenyls in mouse liver DNA. The Toxicologist 1995; 15: 83.
49. WILLIAMS GM: Classification of genotoxic and epigenetic hepatocarcinogens using liver culture assays. Ann NY Acad Sci 1980; 349: 273-282.
50. WILLIAMS GM: Modulation of chemical carcinogenesis by xenobiotics. Fundam Appl Toxicol 1984; 4: 325-344.
51. WILLIAMS GM: Epigenetic promoting effects of butylated hydroxyanisole. Food Chem Toxicol 1986; 24: 1163-1166.
52. WILLIAMS GM: Mongenotoxic mechanisms in carcinogenesis. Banbury Report 1987; 25: 367-380.
53. WILLIAMS GM, MCQUEEN CA, TONG C: Toxicity studies of butylated hydroxyanisole and butylated hydroxytoluene. I. Genetic and cellular effects. Food Chem Toxicol 1990; 28: 793-798.
54. WILLIAMS GM, WEISBURGER JH: Chemical Carcinogenesis. In: AMDUR MO, DOULL J, KLAASEN CD (eds.): CASARETT and DOULL's Toxicology, the Basic Sciences of Poisons. Pergamon Press New York 1991 pp. 127-200.
55. WILLIAMS GM, IATROPOULOS M, WEISBURGER JH: Chemical carcinogen mechanisms of action and implications for testing methodology. Exp Toxic Pathol 1996; 48: 101-111.